EMEA-001314-PIP01-12-M02 - paediatric investigation plan
Dinutuximab beta
PIPHuman
EUSA Pharma (Netherlands) B.V.
Tel. +44 (0)3305 001155
E-mail: Ignacio.AlvarezRojo@eusapharma.com
Recordati Rare Diseases
Tel. +33 1 47 73 64 58
E-mail: RRDinfo@recordati.com